Oncocyte Corporation. (OCX) NASDAQ
$2.95 0.05 (1.72%)
Market Cap: $39.43M
As of 05/15/24 04:00 PM EDT. Market closed.
Oncocyte Corporation. (OCX)
NASDAQ
$2.95
0.05 (1.72%)
Market Cap: $39.43M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
oncocyte is focused on the discovery, development, and commercialization of non-invasive, liquid biopsy diagnostics to facilitate clinical decision making in the early detection of cancer. the company's pipeline is focused on molecular tests for areas of high unmet need - lung, breast, and bladder cancers - where the current standard of diagnostic care is often ambiguous, costly, and involves ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$400,000
CEO Compensation (Total)
$925,808
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$400,000
CEO Compensation (Total)
$925,808
URL
Address
15 Cushing, California, Irvine, 92618.
PRICE CHART FOR ONCOCYTE CORPORATION
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.85
Previous Close
$2.90
Days Range
$2.80 - $2.98
52 week range
$2.08 - $5.40
Volume
32,627
Avg. Volume (30 days)
28,437
Market Cap
$39.43M
Dividend Yield
-
P/E
(1.37)
Shares Outstanding
13,364,637
Open
$2.85
Previous Close
$2.90
Days Range
$2.80 - $2.98
52 week range
$2.08 - $5.40
Volume
32,627
Avg. Volume (30 days)
28,437
Market Cap
$39.43M
Dividend Yield
-
P/E
(1.37)
Shares Outstanding
13,364,637
FINANCIAL STATEMENTS FOR ONCOCYTE CORPORATION
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ONCOCYTE CORPORATION
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Apr 11, 2024 | Buy | $2.92 | 2,420,000 | 7,057,688 | 4,929,066 | Apr 15, 2024, 07:21 PM |
| Riggs Josh | CEO and President | Apr 11, 2024 | Buy | $2.95 | 3,390 | 10,001 | 3,505 | Apr 15, 2024, 06:04 AM |
| Arno Andrew | Director | Apr 11, 2024 | Buy | $2.95 | 33,898 | 99,999 | 69,054 | Apr 15, 2024, 06:02 AM |
| KINGSLEY ALFRED D | Director | Jun 14, 2023 | Buy | $0.21 | 30,000 | 6,447 | 469,111 | Jun 15, 2023, 08:13 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 05, 2023 | Buy | $0.30 | 663,000 | 200,027 | 8,090,202 | Apr 07, 2023, 05:12 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Apr 03, 2023 | Buy | $0.30 | 26,827,638 | 8,093,898 | 50,181,335 | Apr 05, 2023, 09:35 PM |
| Gutfreund John Peter | Director | Apr 03, 2023 | Option Exercise | $0.35 | 1,000,000 | 354,400 | 1,075,000 | Apr 05, 2023, 09:30 PM |
| Gutfreund John Peter | Director | Apr 03, 2023 | Option Exercise | $0.35 | 705,000 | 249,852 | 715,000 | Apr 05, 2023, 09:30 PM |
| Arno Andrew | Director | Apr 03, 2023 | Option Exercise | $0.35 | 141,084 | 50,000 | 673,133 | Apr 05, 2023, 09:29 PM |
| Arno Andrew | Director | Apr 03, 2023 | Option Exercise | $0.35 | 282,168 | 100,000 | 156,084 | Apr 05, 2023, 09:29 PM |
| Arno Andrew | Director | Dec 23, 2022 | Buy | $0.35 | 250,000 | 87,875 | 532,049 | Dec 28, 2022, 04:05 PM |
| Gutfreund John Peter | Director | Dec 23, 2022 | Buy | $0.33 | 75,000 | 24,727 | 75,000 | Dec 28, 2022, 04:05 PM |
| KINGSLEY ALFRED D | Director | Dec 22, 2022 | Buy | $0.28 | 25,000 | 7,125 | 439,111 | Dec 27, 2022, 06:47 PM |
| Last Andrew J. | Director | Aug 17, 2022 | Buy | $0.87 | 20,000 | 17,400 | 70,170 | Aug 19, 2022, 08:00 AM |
| Arno Andrew | Director | Aug 17, 2022 | Buy | $0.90 | 15,000 | 13,500 | 15,000 | Aug 19, 2022, 08:00 AM |
| ANDREWS RONALD ASBURY | President & CEO | Aug 16, 2022 | Buy | $0.96 | 40,000 | 38,400 | 333,212 | Aug 18, 2022, 04:05 PM |
| KINGSLEY ALFRED D | Director | Aug 15, 2022 | Buy | $0.97 | 10,000 | 9,700 | 414,111 | Aug 17, 2022, 08:20 PM |
| Gutfreund John Peter | Director | Aug 15, 2022 | Buy | $0.93 | 25,000 | 23,250 | 25,000 | Aug 17, 2022, 08:19 PM |
| GRIFFITH MELINDA | Director | Aug 16, 2022 | Buy | $1.00 | 10,000 | 10,000 | 30,000 | Aug 17, 2022, 08:18 PM |
| Carter Jennifer L. | Director | Aug 16, 2022 | Buy | $0.95 | 10,500 | 9,975 | 30,500 | Aug 17, 2022, 08:17 PM |
| Arno Andrew | Director | Aug 16, 2022 | Buy | $0.97 | 115,523 | 112,057 | 282,049 | Aug 17, 2022, 08:15 PM |
| Arno Andrew | Director | Aug 15, 2022 | Buy | $0.93 | 34,477 | 32,064 | 166,526 | Aug 17, 2022, 08:15 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Jun 24, 2022 | Sale | $1.03 | 46,405 | 47,922 | 7,462,643 | Jun 28, 2022, 07:48 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Jun 24, 2022 | Sale | $1.03 | 52,981 | 54,713 | 8,520,146 | Jun 28, 2022, 07:48 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.25 | 76,840 | 96,184 | 8,532,663 | Jun 28, 2022, 07:46 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.25 | 123,160 | 154,166 | 7,473,607 | Jun 28, 2022, 07:46 PM |
| Yu Li | VP Cntrllr/Prncpl Acctng Offcr | May 18, 2022 | Sale | $1.14 | 8,128 | 9,266 | 16,872 | May 19, 2022, 05:58 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,993,259 | 2,649,813 | 8,532,663 | Apr 29, 2022, 04:33 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,789,058 | 2,373,975 | 7,473,607 | Apr 29, 2022, 04:33 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,381,438 | 1,840,766 | 1,381,438 | Apr 29, 2022, 04:33 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 767,952 | 1,023,296 | 767,952 | Apr 29, 2022, 04:33 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,381,438 | 1,840,766 | 1,381,438 | Apr 18, 2022, 09:55 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 767,952 | 1,023,296 | 767,952 | Apr 18, 2022, 09:55 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,993,259 | 2,649,813 | 8,532,663 | Apr 18, 2022, 09:55 PM |
| PURA VIDA INVESTMENTS, LLC | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 1,789,058 | 2,373,975 | 7,473,607 | Apr 18, 2022, 09:55 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Apr 14, 2022 | Buy | $1.33 | 6,003,752 | 7,999,999 | 23,353,697 | Apr 15, 2022, 06:13 PM |
| Ross Douglas T. | Chief Scientific Officer | Mar 25, 2022 | Buy | $1.40 | 15,000 | 21,000 | 20,317 | Mar 28, 2022, 08:00 PM |
| Paulsen Gisela | Chief Operating Officer | Mar 17, 2022 | Buy | $1.20 | 16,500 | 19,767 | 16,500 | Mar 17, 2022, 09:27 PM |
| ANDREWS RONALD ASBURY | Chief Executive Officer | Mar 16, 2022 | Buy | $1.28 | 50,000 | 64,150 | 293,212 | Mar 17, 2022, 09:26 PM |
| Redmond Cavan M. | Director | Mar 16, 2022 | Buy | $1.19 | 40,000 | 47,560 | 110,863 | Mar 16, 2022, 09:08 PM |
| Levine Mitchell S | Chief Financial Officer | Mar 15, 2022 | Buy | $1.17 | 25,000 | 29,150 | 87,080 | Mar 15, 2022, 04:19 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Sep 23, 2021 | Option Exercise | $3.15 | 573,461 | 1,807,836 | 17,349,945 | Sep 24, 2021, 04:56 PM |
| Last Andrew J. | Director | Jun 11, 2021 | Option Exercise | $3.00 | 6,993 | 20,979 | 30,170 | Jun 14, 2021, 08:20 PM |
| ANDREWS RONALD ASBURY | Chief Executive Officer | Mar 19, 2021 | Buy | $4.79 | 11,000 | 52,702 | 113,698 | Mar 22, 2021, 05:17 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Feb 05, 2021 | Buy | $4.50 | 600,000 | 2,700,000 | 16,776,484 | Feb 09, 2021, 05:21 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Jan 20, 2021 | Buy | $3.42 | 1,460,280 | 4,999,999 | 16,176,484 | Jan 22, 2021, 04:28 PM |
| KINGSLEY ALFRED D | Director | Dec 23, 2020 | Option Exercise | $1.34 | 1,237 | 1,658 | 319,740 | Dec 28, 2020, 09:46 PM |
| KINGSLEY ALFRED D | Director | Dec 28, 2020 | Option Exercise | $1.34 | 65,271 | 87,463 | 384,111 | Dec 28, 2020, 09:46 PM |
| KINGSLEY ALFRED D | Director | Dec 23, 2020 | Sale | $2.55 | 900 | 2,295 | 318,840 | Dec 28, 2020, 09:46 PM |
| KINGSLEY ALFRED D | Director | Dec 22, 2020 | Option Exercise | $1.34 | 10,516 | 14,091 | 326,155 | Dec 23, 2020, 09:12 PM |
| KINGSLEY ALFRED D | Director | Dec 21, 2020 | Option Exercise | $1.34 | 47,976 | 64,288 | 350,787 | Dec 23, 2020, 09:12 PM |
| KINGSLEY ALFRED D | Director | Dec 21, 2020 | Sale | $2.54 | 5,148 | 13,076 | 315,639 | Dec 23, 2020, 09:12 PM |
| Levine Mitchell S | CFO | Sep 12, 2019 | Buy | $2.01 | 10,000 | 20,060 | 13,495 | Dec 17, 2020, 05:02 PM |
| Levine Mitchell S | CFO | Sep 12, 2020 | Buy | $2.01 | 10,000 | 20,060 | 13,495 | Dec 15, 2020, 06:02 AM |
| Parker Albert P | Chief Operating Officer | Aug 03, 2020 | Buy | $1.33 | 5,000 | 6,648 | 5,000 | Aug 05, 2020, 07:36 PM |
| KALAJIAN TONY T | Sr.VP/Chief Accounting Officer | Aug 03, 2020 | Buy | $1.31 | 5,000 | 6,533 | 15,000 | Aug 05, 2020, 07:34 PM |
| ANDREWS RONALD ASBURY | Chief Executive Officer | Aug 03, 2020 | Buy | $1.35 | 40,000 | 53,880 | 102,698 | Aug 04, 2020, 06:50 PM |
| Levine Mitchell S | Chief Financial Officer | Aug 03, 2020 | Buy | $1.32 | 10,000 | 13,200 | 36,579 | Aug 04, 2020, 06:47 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Apr 24, 2020 | Buy | $2.27 | 1,050,000 | 2,383,500 | 14,716,204 | Apr 28, 2020, 06:14 PM |
| ANDREWS RONALD ASBURY | CEO and President | Mar 31, 2020 | Buy | $2.37 | 18,000 | 42,696 | 62,698 | Apr 01, 2020, 09:24 PM |
| ANDREWS RONALD ASBURY | CEO and President | Mar 30, 2020 | Buy | $2.26 | 27,216 | 61,454 | 44,698 | Apr 01, 2020, 09:24 PM |
| ANDREWS RONALD ASBURY | CEO and President | Mar 31, 2020 | Buy | $2372.00 | 18,000 | 42,696,000 | 62,698 | Apr 01, 2020, 04:05 PM |
| ANDREWS RONALD ASBURY | CEO and President | Mar 30, 2020 | Buy | $2.26 | 27,216 | 61,454 | 44,698 | Apr 01, 2020, 04:05 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Jan 02, 2020 | Buy | $2.16 | 1,391,466 | 3,000,001 | 13,666,204 | Jan 06, 2020, 06:38 PM |
| Lineage Cell Therapeutics, Inc. | Previous 10% Owner | Jan 02, 2020 | Sale | $2.16 | 2,383,090 | 5,137,942 | 6,041,154 | Jan 06, 2020, 05:00 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Nov 13, 2019 | Buy | $1.70 | 1,176,471 | 2,000,001 | 12,274,738 | Nov 15, 2019, 05:57 PM |
| Arno Andrew | Director | Sep 17, 2019 | Buy | $2.16 | 50,000 | 108,130 | 102,447 | Sep 18, 2019, 04:59 PM |
| KALAJIAN TONY T | SVP-Chief Accounting Officer | Sep 13, 2019 | Buy | $1.98 | 10,000 | 19,800 | 10,000 | Sep 16, 2019, 05:28 PM |
| Lineage Cell Therapeutics, Inc. | 10% Owner | Sep 11, 2019 | Sale | $1.66 | 4,000,000 | 6,640,000 | 8,424,244 | Sep 13, 2019, 05:20 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Sep 11, 2019 | Buy | $1.66 | 2,000,000 | 3,320,000 | 11,098,267 | Sep 13, 2019, 04:57 PM |
| Levine Mitchell S | Chief Financial Officer | Sep 12, 2019 | Buy | $2.01 | 10,000 | 20,060 | 10,000 | Sep 12, 2019, 06:33 PM |
| BIOTIME INC | 10% Owner | Jul 05, 2019 | Sale | $2.00 | 2,250,000 | 4,500,000 | 12,424,244 | Jul 05, 2019, 04:32 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Jul 02, 2019 | Buy | $2.00 | 1,000,000 | 2,000,000 | 9,098,267 | Jul 02, 2019, 05:16 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Feb 08, 2019 | Buy | $3.75 | 533,333 | 1,999,999 | 8,098,267 | Feb 12, 2019, 05:23 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Mar 28, 2018 | Buy | $1.26 | 3,968,254 | 5,000,000 | 7,564,934 | Mar 30, 2018, 04:28 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Jul 21, 2017 | Option Exercise | $3.25 | 540,000 | 1,755,000 | 3,596,680 | Jul 25, 2017, 05:14 PM |
| BROADWOOD PARTNERS, L.P. | 10% Owner | Feb 17, 2017 | Option Exercise | $3.25 | 425,000 | 1,381,250 | 3,056,680 | Feb 22, 2017, 05:10 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN ONCOCYTE CORPORATION
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 62,433 | 0.00002% | 1.55% | Other |
| BLACKROCK INC. | 60,187 | 0% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 12,218 | 0.00006% | -3.93% | Other |
CHANGE IN SHARES OUTSTANDING FOR ONCOCYTE CORPORATION
STOCK BUYBACKS FOR ONCOCYTE CORPORATION
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.12%
1Q
06/30/2023
2.18%
2Q
03/31/2023
38.63%
3Q
12/31/2022
39.24%
4Q
09/30/2022
39.37%
5Q
06/30/2022
46.25%
6Q
03/31/2022
79.22%
7Q
12/31/2021
79.22%
8Q
09/30/2021
80.77%
9Q
06/30/2021
84.18%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ONCOCYTE CORPORATION
LOADING...